Balance Sheet Data

Boston Scientific Corporation (BSX)

$46.305

+0.68 (+1.48%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 1881462171,7341,9251,003.991,079.581,160.871,248.271,342.25
Total Cash (%)
Account Receivables 1,5481,6081,9331,5311,7782,093.502,251.112,420.602,602.852,798.81
Account Receivables (%)
Inventories 1,0781,1661,5791,3511,6101,678.791,805.191,941.102,087.252,244.40
Inventories (%)
Accounts Payable 530349542513794672.73723.38777.85836.41899.38
Accounts Payable (%)
Capital Expenditure -319-316-461-376-554-498.29-535.80-576.14-619.52-666.16
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.